Position history for SOFTBANK GROUP CORP.'s holdings in RECURSION PHARMACEUTICALS IN
SOFTBANK GROUP CORP. holds 13.6M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $41.9M as of 2026-Q1. RXRX represents 0.4% of SOFTBANK GROUP CORP.'s portfolio.
Current Value
$41.9M
Current Shares
13.6M
Total Value Change
-$57.3M
Total Shares Change
-1M
Other major holders of RXRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BAILLIE GIFFORD & CO
Unchanged |
| 13.6M |
0.0% |
| $41.9M |
| 0.4% |
| $3.54 |
0 |
| 2025-Q4 | Decreased | 13.6M | -7.0% | $55.8M | 0.4% | $4.11 | 0 |
| 2025-Q3 | Unchanged | 14.7M | 0.0% | $71.6M | 0.3% | $4.91 | 0 |
| 2025-Q2 | Unchanged | 14.7M | 0.0% | $74.2M | 0.3% | $5.03 | 0 |
| 2025-Q1 | Unchanged | 14.7M | 0.0% | $77.6M | 0.3% | $5.81 | 0 |
| 2024-Q4 | New | 14.7M | - | $99.2M | 0.4% | $6.77 | 51 |